ImmunityBio, Inc. IBRX FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ImmunityBio, Inc.'s FX effect on cash?
- ImmunityBio, Inc. (IBRX) reported FX effect on cash of $122K in Q1 2026.
- How has ImmunityBio, Inc.'s FX effect on cash changed year-over-year?
- ImmunityBio, Inc.'s FX effect on cash increased by 1320.0% year-over-year, from -$10K to $122K.